These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12052859)

  • 41. A new metabolic disorder in human cationic amino acid transporter-2 that mimics arginase 1 deficiency in newborn screening.
    Yahyaoui R; Blasco-Alonso J; Benito C; Rodríguez-García E; Andrade F; Aldámiz-Echevarría L; Muñoz-Hernández MC; Vega AI; Pérez-Cerdá C; García-Martín ML; Pérez B
    J Inherit Metab Dis; 2019 May; 42(3):407-413. PubMed ID: 30671984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neonatal cholestasis: an uncommon presentation of hyperargininemia.
    Gomes Martins E; Santos Silva E; Vilarinho S; Saudubray JM; Vilarinho L
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S503-6. PubMed ID: 21229317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. L-arginine binding to liver arginase requires proton transfer to gateway residue His141 and coordination of the guanidinium group to the dimanganese(II,II) center.
    Khangulov SV; Sossong TM; Ash DE; Dismukes GC
    Biochemistry; 1998 Jun; 37(23):8539-50. PubMed ID: 9622506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human arginase isozymes.
    Grody WW; Dizikes GJ; Cederbaum SD
    Isozymes Curr Top Biol Med Res; 1987; 13():181-214. PubMed ID: 3583682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A patient with arginase deficiency and episodic hyperammonemia successfully treated with menses cessation.
    Boles RG; Stone ML
    Mol Genet Metab; 2006 Dec; 89(4):390-1. PubMed ID: 16963300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular basis of hyperargininemia: structure-function consequences of mutations in human liver arginase.
    Ash DE; Scolnick LR; Kanyo ZF; Vockley JG; Cederbaum SD; Christianson DW
    Mol Genet Metab; 1998 Aug; 64(4):243-9. PubMed ID: 9758714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.
    Mavri-Damelin D; Eaton S; Damelin LH; Rees M; Hodgson HJ; Selden C
    Int J Biochem Cell Biol; 2007; 39(3):555-64. PubMed ID: 17098461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrent hepatic failure and status epilepticus: an uncommon presentation of hyperargininemia.
    Yucel H; Kasapkara ÇS; Akcaboy M; Aksoy E; Sahin GE; Derinkuyu BE; Senel S; Ceylaner S
    Metab Brain Dis; 2018 Oct; 33(5):1775-1778. PubMed ID: 29961243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arginase I mRNA therapy - a novel approach to rescue arginase 1 enzyme deficiency.
    Asrani KH; Cheng L; Cheng CJ; Subramanian RR
    RNA Biol; 2018; 15(7):914-922. PubMed ID: 29923457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular genetic study of human arginase deficiency.
    Grody WW; Klein D; Dodson AE; Kern RM; Wissmann PB; Goodman BK; Bassand P; Marescau B; Kang SS; Leonard JV
    Am J Hum Genet; 1992 Jun; 50(6):1281-90. PubMed ID: 1598908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arginase and free amino acids in hyperargininemia: leukocyte arginine as a diagnostic parameter for heterozygotes.
    Marescau B; Pintens J; Lowenthal A; Terheggen HG; Adriaenssens K
    J Clin Chem Clin Biochem; 1979 Apr; 17(4):211-7. PubMed ID: 438730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rescue of the Functional Alterations of Motor Cortical Circuits in Arginase Deficiency by Neonatal Gene Therapy.
    Cantero G; Liu XB; Mervis RF; Lazaro MT; Cederbaum SD; Golshani P; Lipshutz GS
    J Neurosci; 2016 Jun; 36(25):6680-90. PubMed ID: 27335400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperargininemic Encephalopathy with Unique Clinical Presentation and Novel Genetic Mutations.
    Nagarjunakonda S; Daggumati R; Amalakanti S
    J Coll Physicians Surg Pak; 2020 May; 30(5):535-536. PubMed ID: 32580855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel complex re-arrangement of ARG1 commonly shared by unrelated patients with hyperargininemia.
    Mohseni J; Boon Hock C; Abdul Razak C; Othman SN; Hayati F; Peitee WO; Haniffa M; Zilfalil BA; Mohd Rawi R; Ngu LH; Sasongko TH
    Gene; 2014 Jan; 533(1):240-5. PubMed ID: 24103480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential expression of the two human arginase genes in hyperargininemia. Enzymatic, pathologic, and molecular analysis.
    Grody WW; Argyle C; Kern RM; Dizikes GJ; Spector EB; Strickland AD; Klein D; Cederbaum SD
    J Clin Invest; 1989 Feb; 83(2):602-9. PubMed ID: 2913054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case series of arginase 1 deficiency: Expanding the spectrum in hyperargininemia.
    Dorum S; Havalı C
    Pediatr Int; 2022 Jan; 64(1):e14945. PubMed ID: 34343381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arginase deficiency with new phenotype and a novel mutation: contemporary summary.
    Tsang JP; Poon WL; Luk HM; Fung CW; Ching CK; Mak CM; Lam CW; Siu TS; Tam S; Wong VC
    Pediatr Neurol; 2012 Oct; 47(4):263-9. PubMed ID: 22964440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pivotal role of inter-organ aspartate metabolism for treatment of mitochondrial aspartate-glutamate carrier 2 (citrin) deficiency, based on the mouse model.
    Saheki T; Moriyama M; Kuroda E; Funahashi A; Yasuda I; Setogawa Y; Gao Q; Ushikai M; Furuie S; Yamamura KI; Takano K; Nakamura Y; Eto K; Kadowaki T; Sinasac DS; Furukawa T; Horiuchi M; Tai YH
    Sci Rep; 2019 Mar; 9(1):4179. PubMed ID: 30862943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of novel ARG1 mutations causing hyperargininemia and correlation with arginase I activity in erythrocytes.
    Carvalho DR; Brand GD; Brum JM; Takata RI; Speck-Martins CE; Pratesi R
    Gene; 2012 Nov; 509(1):124-30. PubMed ID: 22959135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A long-term survival case of arginase deficiency with severe multicystic white matter and compound mutations.
    Segawa Y; Matsufuji M; Itokazu N; Utsunomiya H; Watanabe Y; Yoshino M; Takashima S
    Brain Dev; 2011 Jan; 33(1):45-8. PubMed ID: 20456883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.